Microvast Holdings, Inc.

MVST

CIK 0001760689 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$96M
↓-15.0% -$17Mvs FY2024 (Q4)
Gross Profit
$959K
↓-97.7% -$41Mvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Weak
40/100
  • Profitability
    0ROIC 1.3% (10% = solid, 20%+ = moat)
  • Liquidity
    21Current Ratio 0.92 (above 1.5 = solid)
  • Leverage
    98D/E 0.03 (under 0.5 = conservative)
  • Efficiency
    18Asset Turnover 0.44x (1.0+ = capital-efficient)
  • Growth
    0Revenue YoY -15.0% (10% = solid, 25%+ = elite)
  • Margin Trend
    100Op Margin 10.5% · trend +61.3pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project MVST's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

8%

Trailing CAGR unavailable; default 8%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$2.97
Total enterprise IV
$965M
Diluted shares
0.32B
Terminal PV
$699M (72% of total)
Year-5 FCF
$82M
YearProjected FCFDiscounted PV
+1$61M$55M
+2$65M$54M
+3$71M$53M
+4$76M$52M
+5$82M$51M
Terminal$1.13B$699M

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$20M
investment in PP&E
Stock-based comp (TTM)
$3M
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$1.01B
everything owned
Total liabilities
$595M
everything owed
Stockholders' equity
$411M
shareholder claim
Net debt
$-92M
Net cash position ($92M)

Recent performance · 29 quarters

Revenue↓-15.0% -$17M
$96M
Net Income↓-111.2% -$15M
$-1M
Free Cash Flow↑+174.6% +$10M
$16M
Operating Margin↑+3.5pts
10.5%

Drill down